SCHEMBL6640211

SCHEMBL6640211

CCn1c(=O)ccc2cnc(Nc3ccc(N4CCC(CCCO)CC4)cc3)cc21

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK4 P11802 8/20 0.71
CCND1 P24385 8/20 0.71
CCND2 P30279 8/20 0.71
CCND3 P30281 8/20 0.71
CCNE2 O96020 2/20 0.56
CCNE1 P24864 2/20 0.56
CDK2 P24941 2/20 0.56
FGFR1 P11362 1/20 0.52
CCNA2 P20248 1/20 0.52
FGFR2 P21802 1/20 0.52
FGFR4 P22455 1/20 0.52
FGFR3 P22607 1/20 0.52
CCNA1 P78396 1/20 0.52
BTK Q06187 3/20 0.50
JAK3 P52333 3/20 0.49
LYN P07948 1/20 0.46
SRC P12931 1/20 0.46
WEE1 P30291 2/20 0.43
FYN P06241 2/20 0.43
JAK2 O60674 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6640470 0.89 CDK4 (0.61) CDK4CCND1CCND2CCND3CCNE2
SCHEMBL6640525 0.89 CDK4 (0.59) CDK4CCND1CCND2CCND3CCNE2
SCHEMBL6642058 0.88 CDK4 (0.55) CDK4CCND1CCND2CCND3CCNE2
SCHEMBL6639579 0.87 CDK4 (0.59) CDK4CCND1CCND2CCND3CCNE2
SCHEMBL6642790 0.87 BTK (0.55) CDK4CCND1CCND2CCND3CDK2
SCHEMBL6643006 0.87 CDK4 (0.58) CDK4CCND1CCND2CCND3CCNE2
SCHEMBL6639525 0.85 CDK4 (0.72) CDK4CCND1CCND2CCND3CCNE2
SCHEMBL6641526 0.84 CDK4 (0.71) CDK4CCND1CCND2CCND3CCNE2
SCHEMBL6646298 0.84 CDK4 (0.71) CDK4CCND1CCND2CCND3CCNE2
SCHEMBL6643821 0.84 CDK4 (0.64) CDK4CCND1CCND2CCND3CCNE2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1003745-B1 NAPHTHYRIDINONES FOR INHIBITING PROTEIN TYROSINE KINASE AND CELL CYCLE KINASE MEDIATED CELLULAR PROLIFERATION WARNER LAMBERT CO (US) 2004-12-29 EP claimed
US-6150359-A 1,6-NAPHTHYRIDIONE COMPOUNDS USEFUL FOR TREATING CANCER, RESTENOSIS AND ATHEROSCLEROSIS WARNER-LAMBERT COMPANY (US) 2000-11-21 US claimed
EP-1003745-B1 NAPHTHYRIDINONES FOR INHIBITING PROTEIN TYROSINE KINASE AND CELL CYCLE KINASE MEDIATED CELLULAR PROLIFERATION WARNER LAMBERT CO (US) 2004-12-29 EP disclosed
US-6150359-A 1,6-NAPHTHYRIDIONE COMPOUNDS USEFUL FOR TREATING CANCER, RESTENOSIS AND ATHEROSCLEROSIS WARNER-LAMBERT COMPANY (US) 2000-11-21 US disclosed